The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Celestica, Inc shares valued at $438,694 were purchased by Agrawal Alok K. on May 30 ’25. At $119.47 per share, Agrawal Alok K. acquired 3,672 shares.
Also, Laurette Koellner purchased 100,000 shares, netting a total of over 8,269,000 in proceeds.
Before that, Laurette T Koellner had added 151,717 shares to its account. In a trade valued at $13,945,827, the Director bought Celestica, Inc shares for $91.92 each.
As published in their initiating research note from JP Morgan on February 21, 2025, Celestica, Inc [CLS] has been an Overweight and the price target has been revised to $166. As of January 31, 2025, CIBC has increased its “Neutral” rating to a “Sector outperform” for CLS. Earlier on November 22, 2024, UBS initiated its rating. Their recommendation was “a Neutral” for CLS stock.
Analyzing CLS Stock Performance
On last trading session,, Celestica, Inc [NYSE: CLS] rose 3.08% to $136.25. During the last five days, there has been a surge of approximately 6.70%. Over the course of the year, Celestica, Inc shares have jumped approximately 47.62%. Shares of the company reached a 52-week high of $144.27 on 02/05/25 and a 52-week low of $58.05 on 04/04/25.
Support And Resistance Levels for Celestica, Inc (CLS)
According to the 24-hour chart, there is a support level at 133.11, which, if violated, would cause prices to drop to 129.97. In the upper region, resistance lies at 139.64. The next price resistance is at 143.03. RSI (Relative Strength Index) is 73.66 on the 14-day chart, showing overbought technical sentiment.
Which companies own the most shares of Celestica, Inc (CLS)?
In terms of Celestica, Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 5.92% from the previous closing price of $132.18. Analysts anticipate Celestica, Inc stock to reach 140 by 2025, with the lowest price target being 140. In spite of this, 9 analysts ranked Celestica, Inc stock as Buy at the end of 2025. On November 05, 2024, Barclays assigned a price target of “an Overweight” to the stock and initiated coverage with a $91.
